Logo Twitter Logo Youtube Publications

team members

I joined the team in October 2023 as a PhD student under the supervision of Anne-Lise Pitel and Nicolas Cabé. The aim of my thesis project is to observe the links between physical activity level of Alcohol Use Disorders (AUD) inpatients and AUD-related symptoms, in order to better understand the contribution of physical activity on prevention and care of AUD. This project focuses on 3 key periods: before, during and after hospitalization for alcohol withdrawal and evaluate feasibility and efficiency of APA intervention during and after hospitalization.

Graduated with a Master's degree in neuroscience specialising in behavioural sciences, I joined the team in October 2023 as a PhD student under the supervision of Dr Géraldine Rauchs. As part of my thesis, I'm studying the impact of sleep apnoea on cognition and brain integrity. Using multimodal neuroimaging techniques, this project aims to gain a better understanding of the mechanisms by which sleep apnoea increases the risk of dementia

I initially received an MD and a PhD from the University of Toulouse (France). I am a Professor of Psychiatry at the University of Caen Normandy (France), and adjunct investigator at the Massachusetts General Hospital (Boston, MA) where I served in different leadership capacities as a Harvard Medical School faculty, for nearly ten years. My research focuses specifically on understanding the mechanism and improving the treatment of anxiety and stress-related conditions, including using psychopharmacotherapy and mind-body approaches. To date, I have published over 200 scientific articles and book chapters, and edited two textbooks in the field of anxiety disorders, post-traumatic stress disorder, and prolonged grief disorder. I served as President of the International Society for Traumatic Stress Studies (2020-2021), and currently serve as Associate Editor of the European Journal of Psychotraumatology, and as Editor-in-Chief of the International Journal of Mental Health.

I am a psychiatrist, MD in the addiction medicine department of Caen University Hospital since 2016. My work is shared between a clinical and teaching activity in addiction medicine, and a research activity in psychology and neuroscience. I defended a PhD in psychology in May 2022, supervised by Dr. Anne Lise Pitel. I worked on the cognitive and brain effects of alcohol in patients with alcohol use disorder, in particular impulsivity, and their behavioral and biological mechanisms. I aim simultaneously at evaluating non-pharmacological interventions (e.g., adapted physical activity and virtual reality exposure therapy) to improve cognitive abilities and to favor the reduction of alcohol consumption or abstinence in patients. By joining the NeuroPresage team, I’m thrilled to work with experts in psychological and neuropsychological approaches and non-pharmacological interventions in multiple brain disorders.

I started my PhD under the supervision of Géraldine Rauchs in September 2019. I investigate the sleep alterations occurring during ageing, and their links with memory consolidation and brain alterations. Another aim of my thesis is to better understand the effects of meditation practice on sleep quality in older adults.

I joined Gaël Chételat’s team during a master 2 internship and I am now doing a PhD under the supervision of Dr Robin de Flores. My work aims to better understand and diagnose Alzheimer's disease using medial temporal lobe neuroimaging, and eventually to better cope it through non-pharmacological interventions.

Director of Research at Inserm, I have been working over the last 25 year in the fields of ageing and neurodegenerative diseases. It is a great pleasure, and an honor, to co-lead this dynamic research team, and to work with each of its members, with their different cultures, backgrounds and characters, trying to get everyone to work together in the same direction, with enthusiasm, energy, and in a harmonious way, while encouraging everyone to express and develop their creativity and specificity.

I am a medical biologist from Caen, with a liberal and hospitable experience. During my postgraduate training, I felt the relevance of a therapeutic approach through meditation and mindfulness (MBSR courses – MBCI certificate -Mindfulness Based on Compassion and Insight-, Medicine Meditation and Neuroscience). In order to contribute to the scientific recognition of all the benefits of meditation, I joined the Gaël Chételat's team as a co-investigator in the Age-Well study. I have a lot of fun working in Gaël Chételat’s team. I acquired knowledge and know-how that encourage me to continue the adventure on new neuroscientific projects.

I am a pharmacologist with a strong interest for the field of psychiatry. After my residency I joined the pharmacovigilance and pharmacovigilance of clinical trials units as well as the pharmacoepidemiology unit of Caen University Hospital. Here, I engaged in and spearheaded various research endeavors, notably contributing to studies on medications employed in the treatment of schizophrenia. In order to improve my skills in biostatistics I am getting an MPH from Paris Saclay and I am doing an internship in Nagoya University Hospital at the moment. I am very interested in using real world data in order to improve the care of psychiatry patients.

I am an associate professor in biochemistry and molecular biology and work in the biochemistry department in Caen University Hospital, and joined the Neuropresage team since 2022. I am interested in all aspects of human nutrition. Currently I focus particularly in nutritional disorders and disturbances in the metabolism of micronutrients, vitamins and trace elements in the context of alcohol use disorder.

I am a neurologist (MD) specializing in cognitive disorders and neurodegenerative diseases. I work at the Clinical and Research Memory Center of Lyon (Hospices Civils de Lyon). I joined Dr. Gaël Chételat’s team in 2018 and completed my PhD in neurosciences in September 2021 under her supervision. My research focuses on Behavioral and Psychological Symptoms of neurodegenerative diseases, including Alzheimer’s, Lewy body diseases, and frontotemporal dementia. To investigate these symptoms and their pathophysiological mechanisms, I use multimodal neuroimaging, blood and cerebrospinal fluid biomarkers, as well as clinical, cognitive, sleep, and behavioral assessments.

I’m working as a neuropsychologist and I joined the team in June 2017. I take part in the passing of the neuropsychological tests in the framework of two research projects: the IMAP (Longitudinal Study in Multimodal Imaging of Alzheimer’s Disease at an Early Stage) and the Silver Health Study, a European study on aging well.

I am neurologist, hospital physician, associate professor of neurology at the University of Caen and responsible of the CMRR (Center of Memory) of Caen. There are more than 25 years old that I have a consulting activity specialized in the field of cognitive disorders.

I am professor of psychiatry at University of Caen Normandy and leads researches in schizophrenic disorders with a special focus on neural networks and brain neuromodulation. I coordinate 3 clinical trials using adjunctive therapies in order to investigate their efficacy and impact on the brain in patients with schizophrenia. Two trials test the neuronavigated neurostimulation in patients with negative symptoms or auditory verbal hallucinations. Another investigates the effects of adapted physical activity on clinical, physiological and brain functions.

I joined the team in November 2019 as a clinical research technician for the Age-Well project. I am mainly involved in data acquisition, data entry and data verification. One of my main tasks is, for example, to welcome and accompany the study participants during their examinations.

I am the project manager of the A²M²P University Hospital Federation which is a 5-year long cooperation between clinical and research organizations which aims to produce international level medical research in psychiatry through personalized medicine. I finished my PhD in clinical bioinformatics in 2022 and I joined the Neuropresage team in 2023. My role is to coordinate the project by following and facilitating the advances of each work package.

I joined the team in 2018 as a research assistant in the Age-well project, and I am now doing my PhD on the interactions between lifestyle factors (e.g., cognitive, physical and social activities) and brain markers of Alzheimer’s disease. My interest lies in understanding how modifiable factors such as environment and lifestyle impact brain structure and function, and how they can be targeted to delay cognitive decline in healthy aging as well as in neurodegenerative diseases.

I’m interested in characterizing medial temporal lobe (MTL) alterations in normal and pathological aging. More precisely, I use and develop neuroimaging tools, including structural and functional MRI, to better understand how MTL structures and networks are affected by different conditions. I did my PhD, entitled “Structural, functional and molecular alterations of hippocampal subfields and their networks in normal aging and Alzheimer's disease”, under the supervision of Gael Chételat from 2013 to 2016. I then moved to Philadelphia for a two-year postdoc to continue exploring the MTL with Dr David Wolk and Dr Paul Yushkevich. I came back to Caen in January 2020, riding a seahorse.

Hello ! I am a MD-PhD student, and I started my studies with 3 years of medical school in Toulouse. I validated a M1 of research concurrently, and then a M2 in cognitive sciences. My masters' internships allowed me to study memory with different approaches (human and animal behavior, and mathematical modeling), and to travel to England. I found a similar weather in the city of Caen, where I came in October 2023 for doing a PhD with Eric Bui and Robin de Florès. My work consists in testing wether the integrity of the locus coeruleus is correlated with several markers and symptoms of Alzheimer's disease.

I Joined the team for my Neurosciences master 2 internship. Now, I am starting a PhD thesis under the supervision of Pr Eric Bui, Dr Gaël Chételat and Dr Annick Haelewyn. We are interested in the cerebral functional connectivity in patients with a Prolonged Grief Disorder, a new psychiatric pathology. My main goal will be to investigate the links between functional connectivity and symptoms, and to evaluate the effect of a meditation intervention on them both. It will allow us to better understand this pathology and to provide a complementary therapeutic strategy to these patients.

I joined the Chételat’s lab in 2019 for internships of a master’s degree in neuropsychology and clinical neurosciences and I am now doing my PhD with Gaël Chételat on white matter hyperintensities in AD. I’m also a clinician (MD, geriatrician specialized in neurocognitive disorders), working in Lyon (Clinical and Research Memory Center, Lyon Institute for Aging, Hospices Civils de Lyon, France).

After a PhD in Psychology under the supervision of Dr Béatrice Desgranges (Inserm U923, Caen), a first postdoc in Dr Gaël Chetelat’s lab and a second postdoctoral experience in Dr Sylvia Villeneuve’s lab (Douglas Research Institute/McGill University; Montreal, Canada), I returned to Chetelat’s lab in November 2019 as a postdoctoral researcher. I use multimodal neuroimaging to further understand the physiopathology of Alzheimer’s disease (AD) and the factors that could influence the risk of developing AD in cognitively unimpaired individuals. My work will mainly focus on the influence of lifestyle factors (e.g. cognitive, physical and social activity, diet) on AD brain and cognitive markers and how these factors can interact with other risk factors (e.g. sex, genetics) to modulate AD risk.

Hi! I joined the team since October 2021 for my PhD thesis under the supervision of Dr Géraldine Rauchs and Dr Alison Mary (UR2NF, Belgium). My thesis focuses on the impact of meditation practice on sleep quality and memory consolidation in older adults. Neuroimaging is a totally new field for me, and I will focus my analysis on resting-state functional connectivity.

Hi, I joined the team in 2018 as an intern for my master degree and I am now a PhD student supervised by Dr Gaël Chételat. My project aims at study the impact of meditation on several neuroimaging biomarkers of healthy older adults compared to other forms of mental trainings (english training). This could help us better understand the specifics mechanisms linking meditation and cerebral health.

I joined the team in May 2021 as a neuropsychologist. I’m mainly involved in data acquisition using cognitive evaluations and questionnaires for the Age-Well Project, a European study on aging well. At times, I’m also led to work on the IMAP Project (Longitudinal Study in Multimodal Imaging of Alzheimer’s Disease at an Early Stage).

Hallo! - Dutch greetings - I am a postdoctoral researcher working with dr. Eric Bui (MD) on several projects. I moved from The Netherlands and arrived in France at the beginning of 2022 to join the lab and will stay for at least 1,5 years. In my projects I will mainly focus on the effects of different interventions on symptom reductions in patients with symptoms of prolonged grief disorder and their involved underlying neural and physiological stress mechanisms (mindfulness training - CALM-NiPS pilot study; near-infrared light headband - NIRS study) by using fMRI techniques. At the same time, I am finishing up my PhD trajectory in my home country where I investigated the impact of life adversities on the vulnerability of neurobiological mechanisms underlying posttraumatic stress disorder symptomatology throughout the lifespan.

Hi ! I joined the team in 2022 for my Master's internships. Today, I hold a master's degree in neuroscience and I’m supervised by Dr Gaël Chételat. My neuroimaging work aims to study the effects of a meditation intervention on healthy older adults, compared with a non-native language training and no intervention. On the other hand, I'm trying to determine whether these effects persist in the long term. I'm using multimodal neuroimaging (such as anatomy and metabolism) to further investigate the effects of meditation on the whole brain. Meditation could be a promising approach to preserve the brain from the effects of aging.

Hello! I joined Gaël Chételat’s team in September 2021 as a software engineer. I worked on recreating FDG PET with other images, like MRIs and early PET AV45 with image analysis and deep learning. I started my PhD thesis in computer science under the supervision of Gaël Chételat (PhIND), Abderrahim Elmoataz (GREYC) and the company Forlabs since March 2022. My research focuses on Alzheimer’s disease with the Agewell and IMAP databases, in particular to build algorithms to predict Alzheimer’s disease and to help the patient’s follow-up.

I am engineer in developing applications in our lab and mainly in Gaël’s team since 2008. I implement new innovative methods of processing and analysis in multimodal neuroimaging, mainly in resting-state fMRI. I study the alteration of functional connectivity at rest and links with atrophy, hypometabolism, and amyloid deposits in Alzheimer’s disease. I am responsible for training members of the unit to these techniques. I interact with common services in Imaging and Computer of GIP Cyceron.

Since my PhD supervised by Anne-Lise Pitel and Géraldine Rauchs (ALCOSLEEP project), my research topic focuses on improving the understanding of alcohol-induced sleep alterations, as they play an important role in the development and maintenance of Alcohol Use Disorders (AUD). I have developed considerable expertise in the exploration of subjective and objective sleep disturbances in severe AUD patients, and on their relationships with alcohol-related brain and cognitive alterations. My postdoctoral fellowship supervised by Pierre Maurage (2020-2021, LEP lab, UCLouvain, Belgium) contributed to develop my interest in social neurosciences studies, investigating the neural correlates of metadehumanization in healthy controls and AUD patients. I am currently Lecturer in Neuropsychology at the University of Rouen, and director of the Master degree of Neuropsychology.

Clinical Research Nurse in mental Health and referent at the neuronavigated neurostimulation treatment, I am supporting patient in their journey along their entries in divers research protocols. As my interests have always been advocate patient first, I am using my 20 years of nursing international experience, my BSc in clinical photography and my MSc in Ethic in heath to focus my duties at the side of the FHU A²M²P to support and improve patients' journey in care.

I have been working in Gaël Chételat's team for 6 years, first as a communication officer and clinical research technician for the European project H2020 Medit-Ageing/Silver Santé Study and now as a "polyvalent assistant" (administrative, financial, HR and communication). My role is to implement the different actions of the communication of the team and to animate the contents of the websites and social networks. At the same time, I assist the managers and take care of part of the administrative and financial management of the team. "What I enjoy in my job is to wear different hats!"

Hello everyone! I joined the team in January 2022 as an intern for my Master degree. Since November 2022, I'm a PhD student and my research focus on the link between telomeres and telomerase with the cognitive and cerebral modifications in healthy aging under the supervision of Geraldine Poisnel. I aim to better understand the underlying processes of the relationship between biological and cerebral aging.

I am involved in research on schizophrenia in collaboration with Professor Sonia Dollfus. My role is to analyze resting-state functional imaging data to understand brain function in this pathology. I focus on the preprocessing of imaging data, the comparative analysis of resting-state networks in patients and healthy subjects, and the impact of various therapeutic interventions on these networks. Overall, I am contributing to a better understanding of schizophrenia and exploring therapeutic approaches through the analysis of resting-state functional brain data.

I am a research engineer. After a thesis in human imaging in order to highlight the organization of the macro- (volumetry) and microstructure (integrity via DTI) of white matter (WM) in healthy volunteers, I did my postdoc under the supervision of Pr. Sonia Dollfus in order to characterize the abnormalities of this structure in patients with schizophrenia and bipolar disorder and, more broadly, to better understand the pathophysiology of schizophrenia. Thus, in this perspective, I studied the WM in patients with auditory verbal hallucinations in order to identify specific brain markers of the patients' symptomatology and I am also interested in the effects of antipsychotics and adapted physical activity, as drug and adjuvant non-pharmacological therapies respectively, on the patients' WM and other brain structures such as hippocampal subfields.

I’m a medical student and I joined the team in 2021 for my master 2 internship. I am using PEPSY MRS data to assess the impact of adapted physical activity on hippocampal NAA in subjects with schizophrenia. I will now start a PhD thesis under the supervision of Pr Sonia Dollfus. The main goal of my project is to demonstrate the relevance of self-assessments in clinical practice, research and for the detection of psychotic disorders.

I have been working as an engineer in the team since 2002. My main role is to coordinate the technical aspects of clinical studies. I am also responsible for the acquisition of imaging data, including MRI and PET scans, in interaction with the staff of the neuroimaging platform Cyceron. I also work in close interaction with Brigitte Landeau, for the quality control of imaging data and for the development of neuroimaging data processing techniques. I am responsible for training of clinical research technicians and students in the acquisition, processing and statistical analyses of imaging data.

Graduated with a master’s degree in cognitive neuropsychology and neuroimaging, I joined the team since October 2023 as a PhD student, under the supervision of Dr. Géraldine Rauchs. My project aims at understanding the relationships between sleep quality, amyloid pathology and cognitive decline in the elderly, in order to identify sleep-related risk factors that could be addressed to delay the onset or slow the progression of Alzheimer’s disease. This project relies on the use of multimodal sleep assessment and neuroimaging techniques, including a new device called Somno-Art to assess sleep at home across multiple nights and amyloid PET imaging.

Hi, I’m a PhD student under the supervision of Géraldine Poisnel and Gaël Chételat (UMR-S 1237). My really cool thesis project aims at understanding the impact of mental training (meditation and English learning) on the allostatic load (a cumulative measure of different blood biomarkers), an index of successful aging! I also take part in data acquisition.

I have been working on the effect of chronic and heavy alcohol consumption on brain and cognition for almost 20 years. I have significantly contributed to the understanding of the cognitive and brain pathophysiology of alcohol use disorder and Korsakoff’s syndrome. By joining Gaël’s lab, I plan to extend my investigations to older subjects with alcohol use disorder in order to determine the contribution of alcohol consumption to the development of neurodegenerative diseases.

After a PhD in pharmacology, experiences in pharma industry and a master’s degree in project management, I joined the Gaël Chételat's team. I have been working here for more than 8 years now, first as a project manager on the IMAP+ longitudinal multimodal neuroimaging trial, then as a workpackage "management and coordination" leader of the European project H2020 Medit-Ageing/Silver Santé Study. I have a dual role as I am responsible for management and research support tasks and for a research axis on blood-based biomarkers. My research project is mainly focus on better understanding mechanisms underlying age-related changes in brain using blood-based markers.

I am collaborating with Gaël for several years. I am a sleep scientist in the research unit NIMH (Inserm U1077). I am interested in the role of sleep in memory consolidation and the impact of sleep disturbances on structural, functional and molecular brain alterations. In the AGEWELL project, I am responsible of sleep examinations and I co-supervise with Gaël two PhD students (Valentin Ourry and Pierre Champetier). We work in close interaction with the Sleep department of the University Hospital and with the neuroimaging experts of Gaël’s team.

I have been working on the neural networks of cognitive deficits, particularly language and social cognition, in patients with schizophrenia for almost 20 years. I work now on psychophysiological and neuroimaging biomarkers of the stress response in patients with prolonged grief disorder. By joining Gaël’s lab, I aim at setting-up and testing non-pharmacological intervention protocols such as mindfulness meditation to decrease stress reactivity by improving emotional regulation.

I aim to disentangle the complexity of the brain changes in dementia and normal ageing and their association with behavioural and cognitive impairments. To achieve this goal, I combined PET and MRI multimodal imaging. I started my post-doctoral research at the University of Strasbourg (ICube laboratory, Integrative multimodal imaging for health Team), focusing on dementia with lewy bodies, before I relocated to the University of Sydney (Frontier Research Clinic, MIND team) where I pursued my research in Frontotemporal dementia and normal ageing. I joined Chételat’s lab in May 2021 as a postdoctoral researcher to investigate the role of dual phase PET as a biomarker of Alzheimer’s disease. With a single PET acquisition, I aim to provide a triple signature biomarker for brain perfusion, amyloid burden and white matter lesions.

I am a psychiatrist, hospital physician at the Centre Hospitalier du Rouvray in Rouen. I am working, with Pr Dollfus, on the validation of the MIMO application, a new way for schizophrenic patients to self-assess their auditory hallucinations. And I am training in neuroimaging to identify predictors of response to neurostimulation treatment in resistant depression.

Hi ! I'm a PhD student supervised by Dr Anne-Lise Pitel and I had the opportunity to join the team in October 2022. My work aims at studying normal and pathological aging in patient with an alcohol use disorder. I use multimodal brain imaging and neuropsychological tests to study both cerebral and cognitive aging.

I carried out my PhD entitled: “Subclinical depressive symptoms in older adults and risk of Alzheimer’s disease: associations with multimodal neuroimaging and blood markers of stress, and evaluation of the impact of the COVID-19 pandemic and a meditation intervention” under the supervision of Dr Gaël Chételat and Dr Géraldine Poisnel (2018-2022). Now, I hold a post-doctoral position supervised by Dr Julie Gonneaud, which aims to determine sex-specific risk profiles related to Alzheimer’s disease hallmarks (i.e., neurodegeneration, amyloid, and tau) by combining multiple risk factors (i.e., cardiovascular, lifestyle, psychological factors, and inflammatory markers).

I am MD in the department of psychiatry, CHU de Caen Normandie, and last year PhD student under the supervision of Pr. Sonia Dollfus and Pr.Gaëlle Quarck. I joined the NeuroPresage lab in 2022. The aim of my thesis project is to study the effect of a web-based adapted physical activity program versus health education program in patients with schizophrenia and healthy volunteers in a randomized, controlled trial (PEPSY V@SI) on cardiorespiratory fitness, clinical, biological and psychopathological variables.

Hi, graduated with a Master’s degree Neuroscience-Neurobiology, I joined the Chételat’s Lab in January 2022 to carry out a thesis project under the supervision of Julie Gonneaud (UMR-S 1237). The main goal of my project is to study the influence of lifestyle factors on cognition as well as biomarkers of healthy aging and Alzheimer’s disease. This project requires the use of new techniques for me and it will allow to learn more about this link between neurodegenerative diseases and lifestyle impact and how it can prevent them.

Claire André


Email :

Claire was a PhD student under the supervision of Géraldine Rauchs (Inserm U1077 unit) and Gaël from 2015 to 2019. Her project aims to better understand the relationships between sleep quality, the risk of cognitive decline, and Alzheimer’s disease biomarkers in multimodal neuroimaging. She also took part in data acquisition and the everyday life of the protocole, and put electrodes on a lot of heads ! Sleep well, age well !​

Eider Arenaza Urquijo


Email :

Eider is interested in the neural underpinnings of normal cognition in the setting of Alzheimer’s disease. Her research notably focused on how lifestyle factors (e.g., cognitive, physical and social engagement) influence brain structure and function, relate to Alzheimer’s disease pathological processes and interact with genectic risk.

Alexandre Bejanin


Email :

Alex joined Chételat’s Lab in 2016. His research focused on the similarities and differences in pathophysiological processes between Alzheimer’s disease and frontotemporal dementia through multimodal neuroimaging. His academic background includes a PhD at the University of Caen Normandy, under Dr. Béatrice Desgranges’s supervision, on social cognition in semantic dementia. In 2015-2016, he worked with Dr. Gil Rabinovici as a postdoctoral researcher, at University of California San Francisco (UCSF), on Tau imaging in distinct neurodegenerative disorders and longitudinal metabolic in frontotemporal dementia

Victor Ferment


Email :

My name is Victor, I’m from Le Havre and I have a Master’s degree in cellular biology. At Cyceron, I’m a research assistant in clinical research on Gaël Chételat’s team and I work on the Age-Well project. I am mainly in charge of data acquisition and data entry.

Elizabeth Kuhn


Email :

Since 2017, I am a PhD student under the supervision of Dr Gaël Chételat and the co-supervision of Pr Vincent de La Sayette. My research interest focuses on the evolution of awareness of one’s own cognitive abilities during Alzheimer’s clinical syndrome. I am interest in the brain substrates of self-awareness, its links to cognitive decline and the impact of 18-month non-pharmacological interventions based on cognitive training or meditation training on self-awareness.

Renaud La Joie


Email :

Renaud initially joined the lab in 2008 for a 6-month internship, however, found himself staying involved in the lab for several years to complete both a Master’s degree and a PhD. Renaud worked extensively with high-resolution MRI data to assess hippocampal subfields, helped implement Glorbetapir-PET in the lab to measure amyloid deposition, and played with multimodal imaging to study neurodegenerative processes and their relationships to cognitive deficits. After his defence, Renaud moved to the Bay Area, where he’s been a post-doctoral fellow with Bill Jagust at UC Berkeley, and with Gil Rabinovici at UC San Francisco. In spite of the distance and time difference, Renaud has kept collaborating with Chételat’s lab on a regular basis.

Inès Moulinet


Email :

Hi, her name is Inès Moulinet. She was PhD student and her project aimed at better understanding psycho-affective factors, in normal and pathological ageing (Alzheimer’s disease), using IMAP multimodal data. She also helped with the data acquisition for the Medit-Ageing project.

Justine Mutlu


Email :

Justine Mutlu joined the IMAP team in 2012 to obtain her PhD. Her research work focused on better understanding the links between resting state functional connectivity and atrophy, hypometabolism and amyloid burdern in Alzheimer’s disease. The rest is not silence!

Valentin Ourry


Email :

I joined the team in 2016 as a research assistant, I worked on lifestyle and neuroimaging. I also took part in data acquisition. In 2018, I started a PhD under the supervision of Géraldine Rauchs (Inserm U1077 NIMH) and I work on sleep, lifestyle and multimodal neuroimaging in the context of aging.

Audrey Perrotin


Email :

Audrey was working as an Engineer in the Gaël’s team from 2009 to 2015 – before having to leave for others places…She was especially involved in the IMAP project by managing and coordinating activities between the IMAP members and with associated teams.She has kept on some scientific collaborations with the team. She is particularly interested in studying subjective cognition in AD and how it changes in the course of the pathology, from the subjective cognitive decline (SCD, for more details see the SCD section of the project) at early stages, to anosognosia at later stages (MCI and AD dementia). Neuropsychology and multimodal neuroimaging from the IMAP program offer great means to address these research questions. A pretty long story with subjective memory since it was also the research topic of my PhD (University of Tours, France) and postdoc (University of California, Berkeley, US).

Léo Paly


Email :

I have been part of the team for several years as a neuropsychologist. I take part in the passing of neuropsychological tests in the framework of research project: Silver Santé Study, a European study on aging well and sometimes on the IMAP Project (Longitudinal Study in Multimodal Imaging of Alzheimer’s Disease at an Early Stage).

Stéphane Rehel


Email :

Stéphane was a PhD student supervised by Géraldine Rauchs (Inserm U1077 NIMH) and Gaël Chételat. In the Age-Well project, he was exploring the relationships between sleep, ageing and Alzheimer’s disease biomarkers, focusing more precisely on how these relationships are modulated by cognitive reserve and psycho-affective factors such as anxiety and depression.

Siya Sherif


Email :

Siya was a Research Engineer at Gaël’s Team. He obtained Five year integrated Master’s in Physics from the University of Mysore (India) and carried out his doctoral studies at the IMDEA ( Madrid Institute of Advanced Studies) and Universidad Autónoma de Madrid (Spain). Before joining Cyceron, he was a Research Scientist at the Neuroimaging department of the National Brain Research Centre (India). At present, he was working on the multimodal neuroimaging analysis of Alzheimer’s Disease.

Clémence Tomadesso


Email :

Clémence has been in the lab since 2012 and obtained her doctorate degree in 2018. Her project assessed the links between brain alterations and cognition in patients with Mild Cognitive Impairment. She helped in many aspect of the 2 projects of the team :volunteer’s recruitment, data acquisition, quality check, statistical analyses and educational support for students.

Matthieu Vanhoutte


Email :

Matthieu have a background in physics and biomedical engineering. He first worked as an embedded critical software architect and designer, which allowed him to complete software & system skills needed on any high complexity project. As a research engineer in neuroimaging, he improved his knowledge of PET/MRI imaging and his skills in developing imaging analysis methods in the context of neurodegenerative diseases. Eager to acquire further expertise in these fields, he did a PhD on early onset Alzheimer’s disease neuroimaging, that he obtained in December 2018, and started a Postdoctoral fellowship in Gaël Chételat’s team in February 2019. As a postdoc, he worked on the optimization of early-phase Florbetapir PET imaging as a marker of neurodegeneration.

Caitlin Ware


Email :

I work as a research engineer for Age-Well. My main role is to plan, organize, and help facilitate the English learning intervention for Silver Santé Study. I am also currently writing my PhD on the subject of bilingualism and Alzheimer’s disease at the University of Paris VII Diderot. I conduct research on the psychological and cognitive effects of foreign language learning in older adults. My interests are psychoanalysis, cognitive reserve, and the psychological factors involved in learning a second language.